TA
Tamarack Advisers Portfolio holdings
AUM
$2.12M
This Quarter Return
+42.12%
1 Year Return
-56.28%
3 Year Return
-45.76%
5 Year Return
+44.93%
10 Year Return
–
AUM
$437M
AUM Growth
+$437M
(+14%)
Cap. Flow
+$22.1M
Cap. Flow
% of AUM
5.06%
Top 10 Holdings %
Top 10 Hldgs %
64.24%
Holding
35
New
3
Increased
11
Reduced
11
Closed
3
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
$18M |
| 2 |
Phreesia
PHR
|
$12.2M |
| 3 |
Hologic
HOLX
|
$10.1M |
| 4 |
Viatris
VTRS
|
$9.09M |
| 5 |
Quest Diagnostics
DGX
|
$7.36M |
Top Sells
| 1 |
CMD
Cantel Medical Corporation
CMD
|
$10.1M |
| 2 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$9.71M |
| 3 |
HMSY
HMS Holdings Corp.
HMSY
|
$7.76M |
| 4 |
Pacira BioSciences
PCRX
|
$6.81M |
| 5 |
MDRX
Veradigm Inc. Common Stock
MDRX
|
$5.54M |
Sector Composition
| 1 | Healthcare | 92.48% |
| 2 | Industrials | 4.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Medtronic
MDT
$119B
| $43.8M | 10.02% | 385,000 -15,000 | -4% | -$1.71M |
|
2
Bio-Rad Laboratories Class A
BIO
$8.06B
| $36.7M | 8.38% | 100,000 -15,000 | -13% | -$5.5M |
|
|
MDRX
3
DELISTED
Veradigm Inc. Common Stock
MDRX
| $35.2M | 8.03% | 3,650,000 -575,000 | -14% | -$5.54M |
|
4
AtriCure
ATRC
$1.84B
| $27.9M | 6.38% | 860,000 +10,000 | +1% | +$325K |
|
|
5
Pacira BioSciences
PCRX
$1.2B
| $27.8M | 6.35% | 622,500 -152,500 | -20% | -$6.81M |
|
|
6
Quest Diagnostics
DGX
$20.3B
| $25.7M | 5.88% | 245,000 +70,000 | +40% | +$7.36M |
|
|
7
Hologic
HOLX
$14.9B
| $24.6M | 5.63% | 475,000 +195,000 | +70% | +$10.1M |
|
|
ISEE
8
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $21.6M | 4.93% | 2,650,000 -350,000 | -12% | -$2.85M |
|
9
Zimmer Biomet
ZBH
$21B
| $18.6M | 4.25% | 125,000 -35,000 | -22% | -$5.21M |
|
|
SRCL
10
DELISTED
Stericycle Inc
SRCL
| $18.6M | 4.25% | 300,000 -50,000 | -14% | -$3.1M |
|
|
11
Johnson & Johnson
JNJ
$427B
| $18M | 4.12% | +125,000 | New | +$18M |
|
|
12
Phreesia
PHR
$1.88B
| $17.5M | 4.01% | 660,000 +460,000 | +230% | +$12.2M |
|
|
PTLA
13
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $14.3M | 3.26% | 595,000 -405,000 | -41% | -$9.71M |
|
14
Integer Holdings
ITGR
$3.78B
| $13.4M | 3.05% | 165,000 +50,000 | +43% | +$4.05M |
|
15
United Therapeutics
UTHR
$13.8B
| $13.1M | 2.99% | 151,400 +76,400 | +102% | +$6.61M |
|
16
ICU Medical
ICUI
$3.15B
| $13M | 2.97% | 70,000 +35,000 | +100% | +$6.49M |
|
17
Lantheus
LNTH
$3.73B
| $12.5M | 2.85% | 650,000 -100,000 | -13% | -$1.92M |
|
18
Rigel Pharmaceuticals
RIGL
$697M
| $11.8M | 2.69% | 5,750,000 +275,000 | +5% | +$564K |
|
|
19
Viatris
VTRS
$12.3B
| $9.09M | 2.08% | +450,000 | New | +$9.09M |
|
|
OPTN
20
DELISTED
OptiNose
OPTN
| $8.57M | 1.96% | 1,050,000 +375,000 | +56% | +$3.06M |
|
21
RadNet
RDNT
$5.52B
| $8.27M | 1.89% | 400,000 +75,000 | +23% | +$1.55M |
|
|
STRM
22
DELISTED
Streamline Health Solutions
STRM
| $5.99M | 1.37% | 4,305,882 +2,205,882 | +105% | +$3.07M |
|
23
Inogen
INGN
$216M
| $4.98M | 1.14% | +75,000 | New | +$4.98M |
|
|
NVRO
24
DELISTED
NEVRO CORP.
NVRO
| $4.72M | 1.08% | 40,000 -12,864 | -24% | -$1.52M |
|
|
CORV
25
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $1.02M | 0.23% | 2,500,000 -2,000,000 | -44% | -$815K |
|